Angiogenesis inhibition and lung-cancer therapy
Lancet Oncol
.
2014 Feb;15(2):124-5.
doi: 10.1016/S1470-2045(14)70010-5.
Authors
Amir Onn
1
,
Jair Bar
2
,
Roy S Herbst
3
Affiliations
1
Sheba Medical Center, Institute of Pulmonology, Tel Hashomer, Ramat Gan, Israel.
2
Institute of Oncology, Tel Hashomer, Ramat Gan, Israel.
3
Yale Cancer Center, Section of Medical Oncology, New Haven, CT 06520, USA. Electronic address: roy.herbst@yale.edu.
PMID:
24480554
DOI:
10.1016/S1470-2045(14)70010-5
No abstract available
Publication types
Comment
MeSH terms
Adenocarcinoma / drug therapy*
Adenocarcinoma of Lung
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Male